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Abstract: Percutaneous Coronary Intervention (PCI) procedure increases the risk of inflammation risk and represents 
adverse effects to immune system in the human body. One of the functions in the human body in maintaining the balance of 
immune system is Foxp3 of regulatory T cells and the function of Foxp3 is seldom to be the subject of study in coronary 
patients from the administration of contrast agents after PCI. This study was conducted to analyze the comparison Foxp3 levels 
of regulatory T cells in blood serums in patients who experienced contrast induced nephrophaty (CIN) after PCI procedure for 
both the CIN group and the non-CIN group. The population of coronary patients after PCI. The sample size was 20 patients 
that consisted of 10 patients who experienced CIN and 10 patients who experienced the CIN group. Categorization of both the 
CIN and non-CIN group used Kidney Disease Improving Global Outcomes (KDIGO) and detection of Foxp3 levels in blood 
serums using Enzyme-linked immunosorbent assay (ELISA) technique. Result of this study indicated that the characteristics of 
patients between the CIN group and the non-CIN group did not reveal significant difference, except for the characteristic of 
age. Results of the analysis by using statistical pair and non-pair t-test showed that patients for both the CIN group and non-
CIN group experienced significant reduction of Foxp3 levels of regulatory T cells in their blood serums. This indicated that the 
PCI procedure indeed led to inflammation and Foxp3 levels and it could not be used as the specific marker for CIN incidence, 
but it should be mediated by the inflammation marker. 
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1. Introduction 
Contrast induced nephropaty (CIN) is one of the foremost 
factors for the high risk of acute kidney injury (AKI) 
incidence [1]. Administration of contrast media during 
percutaneous coronary intervention (PCI) at hospitals 
increases the risk of CIN incidence, although there have been 
any risks due to the ascending use of procedure of coronary 
intervention thorough the application of contrast media [2]. 
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Contrast media has cytotoxic effects due to cytotoxity of 
iodine. Free, noncompelexed iodine (I2) and its polarized 
form (H2O I
+
) undergo interaction with amino acids found in 
cell membrane proteins, damaging them and causing loss of 
cell membrane integrity. Through similar processes, iodine 
may exert direct toxicity on vascular cells and renal tubular 
cells [3]. 
Phatogenesis involved in AKI incidence is inflammation 
and this condition is also take places in CIN. Vascular 
endotel disfunction may occur due to the increase of 
inflammatory mediators [4-6]. Regulatory T cells through its 
homeostasis function in immune system have protective 
function on renal and deliver a novel therapeutic target for 
AKI [6]. Theraphy through determination of regulatory T 
cells as the target has proven increase the improvement rate 
and restoration of renal functions. In addition, these 
regulatory T cells have proven useful in reducing 
inflammation by balancing proinflammatory cytokines and 
anti inflammation [7]. The biomarker used to detect 
regulatory T cells is Foxp3 as the transcption factor of 
regulatory T cells [8]. 
Roles and functions of AKI and results of search of literature 
revealed that this study that analyze the condition of regulatory 
T cells in CIN are seldom to be the subject of medical study that 
instigated the authors of this study to analyze Foxp3 levels of 
regulatory T cells for the CIN based on the consideration that 
this study has a valuable scientific contribution for the medical 
treatment of CIN and prevention of AKI. 
2. Materials and Methods 
Experimental design used in this study was cross sectional 
design for the population of cardiovascular patients who 
underwent PCI through the comparison between the CIN 
group and the non-CIN group. The total samples were 20 
patients. All experimental procedures for the treatment of 
patients were reviewed and approved by the Research Ethics 
Committee of Medicine Faculty of Hasanuddin University as 
stated in the Recommendation of Research Ethics issued in 
the registration no. UH16090750. 
Detection of CIN was conducted at the Clinical Pathology and 
Medical Laboratory at Hasanuddin University. CIN criteria 
referred to the Kidney Disease Improving Global Outcomes 
(KDIGO) of the year 2012 based on an increase in serum 
creatinine by either ≥0.5 mg/dL or by ≥25% from baseline within 
48 hours from the administration of radiographic contrast media 
after other causes of renal impairment have been excluded. 
2.1. Detection of Foxp3 Levels of Regulatory T Cells 
Samples to determine Foxp3 levels of regulatory T cells were 
blood serums. Each sample consisted of 3 ml of blood of 
patients. Detection of Foxp3 levels of regulatory T cells in blood 
serums used Human Kit ELISA of the lifespan biosciences 
(LSBio) and the standard procedure set in the LSBio. 
This test used the enzyme-linked immunoabsorbant assay 
(ELISA) technique. Each well of a microtiter plate was stained 
with antibodies specific to Foxp3
+
. Standard samples were put 
into the wells and the samples that contained Foxp3
+
 formed 
chemical bonds with capture antibodies. Standard sampels that 
did not form chemical bonds with capture antibodies were 
excluded by washing. Biotin conjugated antibodies were then 
added later to form chemical bonds with antigens. 
Antibodies that did not form chemical bonds with antigens 
were excluded by washing. Avidin conjugated to Horseradish 
Peroxidase (HRP) were then put into each well and were then 
incubated. Avidin-HRP Conjugate was then formed chemical 
bonds with biotin. Samples that did not form chemical bonds 
with Avidin-HRP Conjugate were excluded by washing. 
After substrats of TMB were added, only wells that contained 
Foxp3
+
, biotin-conjugated antibody and conjugated avidin 
enzymes underwent the alteration of colors. Substrate-
enzyme reactions were discontinued by added sulphuric acid 
solution and the alteration of colors was measured using 
spektrofotometer at the 450 nm ± 10 nm wavelengths. 
Foxp3
+
 concentrations in samples were then measured 
through the comparison between Optical Density (OD) in the 
treated samples and the OD in the standard. 
2.2. Statistic Analysis 
The experimental data were represented in the form tables 
that included mean and standard deviation. The statistical test 
used to determine the mean difference of between the CIN 
group and the non-CIN group was independent-t test. Mean 
difference values before and after the treatment. 
3. Results 
Cardiovascular patients who were administered by contrast 
media were classified into both the CIN and the non-CIN 
groups based on the category of KDIGO. Table 1 that 
indicated the characteristics for the CIN group and the non-
CIN group did not show statistically significant difference in 
baseline characteristics, except for the age. Patients in the 
CIN group had higher mean age. 
Table 1. Baseline Characteristics of Samples for both the CIN and the non-
CIN Groups. 
Characteristics 
Groups 
p Non-CIN 
(n = 10) 
CIN  
(n = 10) 
Gender Male 9 (90%) 9 (90%) 
1.000* 
 Female 1 (10%) 1 (10%) 
Diagnosis CAD 1 6 (60%) 4 (40%) 
0.558*  CAD 2 2 (20%) 1 (10%) 
 CAD 3 2 (20%) 5 (50%) 
Complication 
Diabetes 
mellitus 
1 (10%) 6 (60%) 0.400 
 Hypertension 1 (10%) 8 (80%) 0.467 
Age 
(Mean±SD) 
Year 
 45.00± 9.75 59.00± 5.06 0.002** 
*Chi-Square test 
**Mann-Whitney test 
CAD = coronary artery disease, SD = Deviation Standard 
Comparative analysis for Foxp3 levels s of regulatory T 
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cells in serums between the CIN group and the non-CIN 
group indicated that patients for the two groups collectively 
experienced the reduction of Foxp3 levels of regulatory T 
cells after the administration of contrast media in which 
patients of the non-CIN group had higher reduction than the 
CIN group although the CIN group also had statistically 
significant reduction (Table 2). 
Table 2. Comparison of Foxp3 levels of regulatory T cells in serums between the CIN Group and non-CIN Group. 
Groups 
Foxp3 levels of Regulatory T cells in Blood Serums (ng/ml) 
Mean Difference p 
Pre-treatment Post-treatment 
Non-CIN 2.64+0.71 5.43+0.55 2.79 0.000* 
CIN 1.55+0.51 3.97+0.73 2.42 0.000* 
Mean difference 1.09 1.46   
p 0.000** 0.000**   
*Paired-t test 
**Independent-t test 
4. Discussion 
The significant difference of characteristics between the 
CIN and the non-CIN is evidenced for the age characteristic, 
and age factor is indeed as the predictor for the CIN 
incidence among cardiovascular patients administered by 
contrast media [9, 10]. Older patients face more risk the CIN 
incidence after the administration of contrast agents. 
After PCI, Foxp3 levels of regulatory T cells in blood 
serums underwent significant reduction either at the CIN 
group or the Non-CIN group. PCI is considered has valuable 
effect due to its function to eliminate plugs, but other hand, 
this procedure may trigger inflammatory responses [11]. 
During inflammation, several proinflammatory cytokines that 
include tumor necrosis factor (TNF-α) may suppress function 
of Foxp3 through some certain mechanisms that include 
reduction of phosporilization of Foxp3 [12, 13]. Migration of 
Foxp3 of regulatory T cells to the injured tissues may also to 
be the mechanism cause of the reduction of Foxp3 levels of 
regulatory T cells in serum at the area of periphery [14]. 
After PCI, this study is consistent with other studies that the 
increase of inflammation biomarkers lead to the damage of 
endotel that trigger coronary spams which in turn lead to 
aggregation of thrombosites [15, 16]. This indicated that the 
PCI procedure indeed led to inflammation and Foxp3 levels 
and it could not be used as the specific marker for CIN 
incidence, but it should be mediated by the inflammation 
marker. 
This study proved evidence that PCI procedure could 
cause adverse effect to the balance of immune system and to 
be the causal factor for the risk of renal failure. In addition to 
that, analysis of comparison between the CIN and non-CIN 
group indicated that although there were several patients did 
not experience CIN, PCI procedure still lead to significant 
effect to the reduction of Foxp3 levels of regulatory T cells. 
This study paves away to conduct further researches to study 
the effect of PCI on inflammation by detecting biomarkers of 
inflammation for both the CIN and non-CIN groups. 
5. Conclusion 
Reduction of Foxp3 levels of regulatory T cells in blood 
serums indicated that inflammation occurred after PCI 
procedure among patients who experienced CIN incidence or 
non-CIN and indicated that the PCI procedure indeed led to 
inflammation and Foxp3 levels and it could not be used as 
the specific marker for CIN incidence, but it should be 
mediated by the inflammation marker. 
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